[1]FERLAY J,COLOMBET M,SOERJOMATARAM I,et al.Cancer statistics for the year 2020:An overview[J].International Journal of Cancer,2021,149(4):778-789.
[2]LIANG H,FAN JH,QIAO YL.Epidemiology,etiology,and prevention of esophageal squamous cell carcinoma in China[J].Cancer Biology & Medicine,2017,14(1):33-41.
[3]ABDEL-HAMID NM,ABASS SA.Matrix metalloproteinase contribution in management of cancer proliferation,metastasis and drug targeting[J].Molecular Biology Reports,2021,48(9):6525-6538.
[4]CABRAL-PACHECO GA,GARZA-VELOZ I,CASTRUITA-DE LA ROSA C,et al.The roles of matrix metalloproteinases and their inhibitors in human diseases[J].International Journal of Molecular Sciences,2020,21(24):E9739.
[5]吴伟东,侯文进,刘丹,等.MMP-3、MMP-9和TIMP-1的动态平衡可作为心肌基质重构的重要标志[J].分子影像学杂志,2015,38(02):84-88.
WU WD,HOU WJ,LIU D,et al.The homeostasis of MMP-3,MMP-9 and TIMP-1 can be used as an important sign of myocardial matrix reconstruction[J].Journal of Molecular Imaging,2015,38(02):84-88.
[6]刘清峰,吴伟东,古佳升,等.肿瘤标志物ESM-1 MMP-2和MMP-9鉴别良恶性胸腔积液的临床意义[J].中国临床新医学,2021,14(10):1027-1031.
LIU QF,WU WD,GU JS,et al.Clinical significance of tumor markers ESM-1,MMP-2 and MMP-9 in identifying benign and malignant pleural effusions[J].Chinese Journal of New Clinical Medicine,2021,14(10):1027-1031.
[7]JONSSON A,FALK P,ANGENETE E,et al.Plasma MMP-1 expression as a prognostic factor in colon cancer[J].Journal of Surgical Research,2021,266:254-260.
[8]KURNIA I,RAUF S,HATTA M,et al.Molecular patho-mechanisms of cervical cancer (MMP1)[J].Annals of Medicine and Surgery,2022,77:103415.
[9]WEI X,ZHANG B,PAN B.MMP1 is a prognostic-related biomarker and correlated with immune infiltration in breast cancer[J].Health,2022,14(02):219.
[10]MING XY,ZHANG X,CAO TT,et al.RHCG suppresses tumorigenicity and metastasis in esophageal squamous cell carcinoma via inhibiting NF-κB signaling and MMP1 expression[J].Theranostics,2018,8(1):185-198.
[11]ZOU S,YANG J,GUO J,et al.RAD18 promotes the migration and invasion of esophageal squamous cell cancer via the JNK-MMPs pathway[J].Cancer Letters,2018,417:65-74.
[12]REN F,SU H,JIANG H,et al.Overexpression of miR-623 suppresses progression of hepatocellular carcinoma via regulating the PI3K/Akt signaling pathway by targeting XRCC5[J].Journal of Cellular Biochemistry,2020,121(1):213-223.
[13]LI Q,LIU J,JIA Y,et al.miR-623 suppresses cell proliferation,migration and invasion through direct inhibition of XRCC5 in breast cancer[J].Aging,2020,12(11):10246-10258.
[14]HAMMASH D,MAHFOOD M,KHODER G,et al.miR-623 targets metalloproteinase-1 and attenuates extravasation of brain metastatic triple-negative breast cancer cells[J].Breast Cancer (Dove Medical Press),2022,14:187-198.
[15]CHEN Y,PENG S,CEN H,et al.MicroRNA hsa-miR-623 directly suppresses MMP1 and attenuates IL-8-induced metastasis in pancreatic cancer[J].International Journal of Oncology,2019,55(1):142-156.
[16]SU H,HU N,YANG HH,et al.Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes[J].Clinical Cancer Research,2011,17(9):2955-2966.
[17]CHEN YK,TUNG CW,LEE JY,et al.Plasma matrix metalloproteinase 1 improves the detection and survival prediction of esophageal squamous cell carcinoma[J].Scientific Reports,2016,6:30057.
[18]LIU M,HU Y,ZHANG MF,et al.MMP1 promotes tumor growth and metastasis in esophageal squamous cell carcinoma[J].Cancer Letters,2016,377(1):97-104.
[19]BOIRE A,COVIC L,AGARWAL A,et al.PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells[J].Cell,2005,120(3):303-313.
[20]JUNCKER-JENSEN A,DERYUGINA E I,RIMANN I,et al.Tumor MMP-1 activates endothelial PAR1 to facilitate vascular intravasation and metastatic dissemination[J].Cancer Research,2013,73(14):4196-4211.
[21]SAITO R,MIKI Y,ISHIDA N,et al.The significance of MMP-1 in EGFR-TKI-resistant lung adenocarcinoma:potential for therapeutic targeting[J].International Journal of Molecular Sciences,2018,19(2):E609.
[22]KIM HW,PARK JE,BAEK M,et al.Matrix metalloproteinase-1 (MMP1) upregulation through promoter hypomethylation enhances tamoxifen resistance in breast cancer[J].Cancers,2022,14(5):1232.
[23]SONG L,LIU H,LIU Q.Matrix metalloproteinase 1 promotes tumorigenesis and inhibits the sensitivity to 5-fluorouracil of nasopharyngeal carcinoma[J].Biomedicine & Pharmacotherapy,2019,118:109120.
[24]ZHOU H,XIANG Q,HU C,et al.Identification of MMP1 as a potential gene conferring erlotinib resistance in non-small cell lung cancer based on bioinformatics analyses[J].Hereditas,2020,157(1):32.
[25]陆艳荣,巴尔夏古丽·扎比胡拉,王海峰.血清微小RNA-623和微小RNA-5703及微小RNA-483-5p与局部晚期食管鳞癌患者新辅助放化疗效果的关系[J].中国医药,2021,16(2):245-249.
LU YR,BALSHAGURI ZABIHULA,WANG HF.Relationship between serum microRNA-623 and microRNA-5703 and microRNA-483-5p and the effect of neoadjuvant radiotherapy in patients with locally advanced esophageal squamous carcinoma[J].Chinese Medicine,2021,16(2):245-249.
[26]张建清.预测新疆不同民族局部晚期食管鳞癌放化疗疗效的血清microRNA初步筛选[D].乌鲁木齐:新疆医科大学,2017.
ZHANG JQ.Preliminary screening of serum microRNAs for predicting the efficacy of radiotherapy for locally advanced esophageal squamous carcinoma in different ethnic groups in Xinjiang[D].Urumchi:Xinjiang Medical University,2017.
[27]CUI D,WANG K,LIU Y,et al.MicroRNA-623 inhibits epithelial-mesenchymal transition to attenuate glioma proliferation by targeting TRIM44[J].OncoTargets and Therapy,2020,13:9291-9303.
[28]JIANG L,YANG W,BIAN W,et al.MicroRNA-623 targets Cyclin D1 to inhibit cell proliferation and enhance the chemosensitivity of cells to 5-fluorouracil in gastric cancer[J].Oncology Research,2018,27(1):19-27.